Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.5.1.52 (
PNGase F
)
1,527
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Using a CD4-binding assay to assess the conformation of the human immunodeficiency virus envelope glycoprotein (CHO+
Env
), we studied the effect of treatment with various glycosidases on the stability of
Env
in denaturing environments and in biological media: cleavage from
Env
of either high-mannose-type glycans (HMT-
Env
) by endoglycosidase H or sialic acid residues (Sial-
Env
) by sialidase did not alter
Env
stability whereas its complete deglycosylation (CHO-
Env
) by
N-glycanase
had a large effect. The influence of glycan removal on
Env
sensitivity to proteases was also studied. Thrombin cleavage within V3 was affected by
N-glycanase
treatment; both HMT-
Env
and CHO-
Env
displayed an increased sensitivity to other endoproteases. Thus, partial deglycosylation increases
Env
sensitivity to proteases but only its total deglycosylation alters its stability.
...
PMID:Effect of various glycosidase treatments on the resistance of the HIV-1 envelope to degradation. 910 16